The TESEO registry and how it can help patients with CAT
Cancer-associated thrombosis management is incredibly challenging because of the high risk of recurrence and severe...
LATEST ARTICLES
Inpatient thromboprophylaxis in cancer patients: what is the evidence? A talk report from the 10th ICTHIC
During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...
Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia and preliminary data from the MATTER study: A talk report from the 10th ICTHIC conference
During the 10th ICTHIC, Dr. Avi Leader (hematologist at Rabin Medical Center in Petah Tikva, Israel) talked about...
CAT treatment in challenging patient categories: what the literature says
Patients with cancer are at high risk of venous thromboembolism (VTE). Fortunately, patient survival, diagnostic tools...
Incidental VTE: to treat or not to treat? – A debate from the 10th ICTHIC
During the 10th ICTHIC, Prof. Marcello di Nisio (University of Chieti, Italy) and Prof. Marc Carrier (Ottawa Hospital...
Use of direct oral anticoagulants in patients with atrial fibrillation and concomitant active cancer
Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...